← Leaderboards
Yu-Xiao Yang
University Of Pennsylvania
$4,905,642
Attributed
$4,905,642
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,613,564 · 2
AHRQ$1,292,078 · 1
VA$0 · 3
By mechanism
R01$4,242,252 · 2
K08$663,390 · 1
I01$0 · 3
Top collaborators
- Loren A. Laine3 shared
- Sameer Dev Saini3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Sean P Hennessy$26,496,214
- Amy Bleakley$5,736,408
- Joel M Gelfand$10,446,570
- Sharon Meropol$749,605
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseHealth SystemSafetyProspectiveDoseChronicPharmaceutical PreparationsVeteransProton Pump InhibitorsGastroesophageal Reflux DiseaseAcidsPennsylvaniaEvaluationAdverse EffectsFractureUniversitiesAdultEconomic EvaluationCostHealthcareColorectal CancerHealthcare SystemsLearningCessation Of Life
Grant awards (23)
Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program$0
I01 · FY2021 · VA
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens$0
I01 · FY2021 · VA · contact PI
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens$0
I01 · FY2020 · VA · contact PI
Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program$0
I01 · FY2020 · VA
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens$0
I01 · FY2020 · VA · contact PI
Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program$0
I01 · FY2019 · VA
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens$0
I01 · FY2018 · VA · contact PI
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS$0
I01 · FY2014 · VA · contact PI
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone$520,444
R01 · FY2013 · AR · contact PI
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS$0
I01 · FY2013 · VA · contact PI
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone$594,783
R01 · FY2012 · AR · contact PI
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS$0
I01 · FY2012 · VA · contact PI
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone$587,293
R01 · FY2011 · AR · contact PI
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men$438,398
R01 · FY2011 · HS · contact PI
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone$632,543
R01 · FY2010 · AR · contact PI
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men$426,528
R01 · FY2010 · HS · contact PI
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone$615,111
R01 · FY2009 · AR · contact PI
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men$427,152
R01 · FY2009 · HS · contact PI
Colon Cancer Risk Modification by PPI and HRI Therapy$132,462
K08 · FY2007 · DK · contact PI
Colon Cancer Risk Modification by PPI and HRI Therapy$132,462
K08 · FY2006 · DK · contact PI
Colon Cancer Risk Modification by PPI and HRI Therapy$133,542
K08 · FY2005 · DK
Colon Cancer Risk Modification by PPI and HRI Therapy$132,462
K08 · FY2004 · DK
Colon Cancer Risk Modification by PPI and HRI Therapy$132,462
K08 · FY2003 · DK